Brown Advisory Inc Bio Rad Laboratories, Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 2,298 shares of BIO stock, worth $760,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,298

Previous 3,520 34.72%

Holding current value

$760,063

Previous $961,000 20.08%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$263.97 - $344.64 $322,571 - $421,150	-1,222 Reduced 34.72%	2,298 $768,000
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $3.47 Million - $4.39 Million	-12,922 Reduced 78.59%	3,520 $961,000
Q1 2024 Apr 24, 2024	BUY	$304.11 - $351.99 $265,488 - $307,287	873 Added 5.61%	16,442 $5.69 Million
Q4 2023 Feb 08, 2024	SELL	$269.37 - $365.04 $253 Million - $343 Million	-940,163 Reduced 98.37%	15,569 $5.03 Million
Q3 2023 Oct 24, 2023	BUY	$350.25 - $422.63 $10.1 Million - $12.1 Million	28,724 Added 3.1%	955,732 $343 Million
Q2 2023 Jul 31, 2023	BUY	$359.49 - $486.4 $29 Million - $39.2 Million	80,607 Added 9.52%	927,008 $351 Million
Q1 2023 May 08, 2023	BUY	$418.69 - $503.0 $10.7 Million - $12.8 Million	25,516 Added 3.11%	846,401 $405 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $15.9 Million - $20.6 Million	45,173 Added 5.82%	820,885 $345 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $80 Million - $109 Million	193,896 Added 33.33%	775,712 $324 Million
Q2 2022 Nov 14, 2022	BUY	$463.67 - $597.16 $37,093 - $47,772	80 Added 0.01%	581,816 $288 Million
Q2 2022 Sep 13, 2022	SELL	$463.67 - $597.16 $21.9 Million - $28.2 Million	-47,144 Reduced 7.49%	582,701 $288 Million
Q2 2022 Aug 02, 2022	BUY	$463.67 - $597.16 $40.6 Million - $52.3 Million	87,596 Added 16.15%	629,845 $314 Million
Q1 2022 Nov 14, 2022	SELL	$524.57 - $735.42 $506,210 - $709,680	-965 Reduced 0.17%	581,736 $328 Million
Q1 2022 Sep 13, 2022	SELL	$524.57 - $735.42 $20.8 Million - $29.2 Million	-39,675 Reduced 6.82%	542,249 $305 Million
Q1 2022 May 09, 2022	BUY	$524.57 - $735.42 $22.3 Million - $31.3 Million	42,563 Added 7.89%	581,924 $330 Million
Q4 2021 Jan 27, 2022	SELL	$708.84 - $794.68 $22.6 Million - $25.3 Million	-31,847 Reduced 5.58%	539,361 $408 Million
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $1.3 Million - $1.63 Million	1,976 Added 0.35%	571,208 $426 Million
Q2 2021 Jul 29, 2021	BUY	$576.64 - $649.04 $21.4 Million - $24 Million	37,045 Added 6.96%	569,232 $367 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $30.9 Million - $37.4 Million	56,515 Added 11.88%	532,187 $304 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $5.24 Million - $6.6 Million	10,263 Added 2.21%	475,672 $277 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $22.8 Million - $26.9 Million	50,277 Added 12.11%	465,409 $240 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $23.7 Million - $34.9 Million	70,846 Added 20.58%	415,132 $187 Million
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $37 Million - $47.4 Million	115,774 Added 50.66%	344,286 $121 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $73.1 Million - $85.5 Million	228,512 New	228,512 $84.6 Million
Q2 2019 Aug 12, 2019	SELL	$286.93 - $312.59 $351,776 - $383,235	-1,226 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $35,663 - $50,468	159 Added 14.9%	1,226 $376,000
Q4 2018 Feb 13, 2019	BUY	$220.1 - $309.0 $30,593 - $42,951	139 Added 14.98%	1,067 $248,000
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $5,207 - $5,870	18 Added 1.98%	928 $291,000
Q2 2018 Aug 10, 2018	SELL	$244.1 - $303.88 $9,764 - $12,155	-40 Reduced 4.21%	910 $262,000
Q1 2018 Jun 28, 2018	BUY	$233.97 - $274.11 $222,271 - $260,404	950 New	950 $238,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Bio Rad Laboratories, Inc. Transaction History